Related Experiment Video
Updated: May 31, 2026
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
RhoA protects the mouse heart against ischemia/reperfusion injury
Sunny Yang Xiang1, Davy Vanhoutte, Dominic P Del Re
1Department of Pharmacology, UCSD, San Diego, California 92093-0636, USA.
Abstract:
The small GTPase RhoA serves as a nodal point for signaling through hormones and mechanical stretch. However, the role of RhoA signaling in cardiac pathophysiology is poorly understood. To address this issue, we generated mice with cardiomyocyte-specific conditional expression of low levels of activated RhoA (CA-RhoA mice) and demonstrated that they exhibited no overt cardiomyopathy. When challenged by in vivo or ex vivo ischemia/reperfusion (I/R), however, the CA-RhoA mice exhibited strikingly increased tolerance to injury, which was manifest as reduced myocardial lactate dehydrogenase (LDH) release and infarct size and improved contractile function. PKD was robustly activated in CA-RhoA hearts. The cardioprotection afforded by RhoA was reversed by PKD inhibition. The hypothesis that activated RhoA and PKD serve protective physiological functions during I/R was supported by several lines of evidence. In WT mice, both RhoA and PKD were rapidly activated during I/R, and blocking PKD augmented I/R injury. In addition, cardiac-specific RhoA-knockout mice showed reduced PKD activation after I/R and strikingly decreased tolerance to I/R injury, as shown by increased infarct size and LDH release. Collectively, our findings provide strong support for the concept that RhoA signaling in adult cardiomyocytes promotes survival. They also reveal unexpected roles for PKD as a downstream mediator of RhoA and in cardioprotection against I/R.
Insights
Activated RhoA signaling in heart cells protects against injury during ischemia/reperfusion (I/R). This cardioprotection involves Protein Kinase D (PKD) activation, revealing a novel survival pathway.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cell Signaling
Background:
- The small GTPase RhoA is a key signaling node for hormones and mechanical stress.
- The specific role of RhoA signaling in cardiac pathophysiology remains largely unknown.
Purpose of the Study:
- To investigate the function of RhoA signaling in cardiomyocyte survival and cardiac response to ischemia/reperfusion (I/R) injury.
- To elucidate the downstream mediators and protective mechanisms of RhoA in the heart.
Main Methods:
- Generation and characterization of cardiomyocyte-specific conditional activated RhoA (CA-RhoA) transgenic mice.
- Assessment of cardiac function and injury in CA-RhoA mice subjected to in vivo and ex vivo I/R challenges.
- Pharmacological inhibition of Protein Kinase D (PKD) and analysis of RhoA-deficient mice during I/R.
Main Results:
- CA-RhoA mice exhibited significantly enhanced tolerance to I/R injury, with reduced infarct size, lower lactate dehydrogenase (LDH) release, and improved cardiac function.
- RhoA activation led to robust activation of PKD, and PKD inhibition abolished the cardioprotective effects of RhoA.
- Wild-type mice showed rapid RhoA and PKD activation during I/R, while blocking PKD exacerbated injury. RhoA-deficient mice displayed reduced PKD activation and impaired I/R tolerance.
Conclusions:
- RhoA signaling in adult cardiomyocytes promotes cell survival and confers significant cardioprotection against I/R injury.
- Protein Kinase D (PKD) acts as a crucial downstream mediator of RhoA-induced cardioprotection.
- The RhoA-PKD pathway represents a novel endogenous mechanism for cardiac protection during ischemic events.
More Related Videos
09:48Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
11:07A Murine Model of Myocardial Ischemia-reperfusion Injury through Ligation of the Left Anterior Descending Artery
Published on: April 10, 2014